Opriessnig, Tanja <br/><br/>
A commercial vaccine based on PCV2a and an experimental vaccine based on a variant mPCV2b are both effective in protecting pigs against challenge with a 2013 U.S. variant mPCV2b strain.  [electronic resource] 

 -  Vaccine  Jan 2014 
 - 230-7 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2518 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2013.11.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Viral--blood<br/>Circoviridae Infections--prevention & control<br/>Circovirus--classification<br/>Cross Protection<br/>Pilot Projects<br/>Random Allocation<br/>Sus scrofa<br/>Swine<br/>Swine Diseases--prevention & control<br/>Viral Vaccines--immunology